Description
A BMI-1 inhibitor (IC50 = ~ 0.5 μM) that irreversibly impairs CIC growth; reduces tumor growth in CIC xenograft assays and abrogates colorectal cancer cell self-renewal in vivo
Formal name: N-(2,6-dibromo-4-methoxyphenyl)-4-(2-methylimidazo[1,2-a]pyrimidin-3-yl)-2-thiazolamine
Synonyms:
Molecular weight: 495.2
CAS: 315704-66-6
Purity: ≥95%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Inhibitors||Research Area|Cancer|Cancer Stem Cell Research|Proliferation||Research Area|Cancer|Cell Cycle